XML 54 R7.htm IDEA: XBRL DOCUMENT v3.20.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Parent
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Deferred Compensation Employee Stock Trust, Net
Employee Stock Trust
Noncontrolling Interest
Total
Increase (Decrease) in Stockholders' Equity                  
Adoption of accounting standards $ 1,393       $ 1,393       $ 1,393
Balance at Dec. 31, 2018 1,949,470 $ 936 $ 1,489,816 $ (8,627) 466,737 $ 825 $ (217) $ 24,423 1,973,893
Balance (in shares) at Dec. 31, 2018   93,610,000         11,000    
Increase (Decrease) in Stockholders' Equity                  
Net income 38,786       38,786     991 39,777
Other comprehensive loss 7,565     7,565         7,565
Stock-based compensation expense 2,354   2,354           2,354
Common stock issued to board members 140   140           140
Common stock issued to board members (in shares)   8,000              
Issuance of common stock related to share-based awards, net (723) $ 2 (725)           (723)
Issuance of common stock related to share-based awards, net (in shares)   203,000              
Dividends on common stock (7,464)       (7,464)       (7,464)
Deferred compensation plan 6         2 $ 4   6
Net cash distributed to noncontrolling interest               (1,810) (1,810)
Balance at Mar. 31, 2019 1,991,527 $ 938 1,491,585 (1,062) 499,452 827 $ (213) 23,604 2,015,131
Balance (in shares) at Mar. 31, 2019   93,821,000         11,000    
Increase (Decrease) in Stockholders' Equity                  
Adoption of accounting standards (5,691)       (5,691)       (5,691)
Balance at Dec. 31, 2019 2,103,039 $ 906 1,445,233 11,419 644,860 776 $ (155) 25,757 2,128,796
Balance (in shares) at Dec. 31, 2019   90,641,000         8,000    
Increase (Decrease) in Stockholders' Equity                  
Net income 49,636       49,636     3,966 53,602
Other comprehensive loss 9,520     9,520         9,520
Stock-based compensation expense 3,642   3,642           3,642
Common stock issued to board members 146   146           146
Common stock issued to board members (in shares)   10,000              
Issuance of common stock related to share-based awards, net (469) $ 2 (471)           (469)
Issuance of common stock related to share-based awards, net (in shares)   158,000              
Repurchases of common stock (14,957) $ (7) (11,249)   (3,701)       $ (14,957)
Repurchases of common stock (in shares)   (701,000)             (700,901)
Dividends on common stock (8,158)       (8,158)       $ (8,158)
Deferred compensation plan 3         (2) $ 5   3
Net cash distributed to noncontrolling interest               (2,701) (2,701)
Balance at Mar. 31, 2020 $ 2,136,711 $ 901 $ 1,437,301 $ 20,939 $ 676,946 $ 774 $ (150) $ 27,022 $ 2,163,733
Balance (in shares) at Mar. 31, 2020   90,108,000         8,000